Document ID: chunk:federal_register_of_legislation:F2025C00119:clause:3_1:p1
Version: federal_register_of_legislation:F2025C00119
Segment Type: clause
Provision Reference: sch 3 cl 1 (pt 1/69)
Character Range: 162297–172883

1  Circumstances and purposes
  The following table sets out:
 (a) circumstances for circumstances codes, for the purposes of sections 12 and 23; and
 (b) purposes for purposes codes, for the purposes of sections 14 to 17; and
 (c) for the purposes of section 13, information relating to how authorisation is obtained when the circumstances for writing a prescription include an authorisation requirement.

Circumstances Code  Purposes Code                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Authority Requirements
                                   Listed Drug                                                                  Circumstances and Purposes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (part of Circumstances)
C4139                              Granisetron                                                                  Nausea and vomiting
                                                                                                                The condition must be associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration.
C4216                              Aprepitant                                                                   Nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures ‑ Streamlined Authority Code 4216
                                                                                                                The condition must be associated with cytotoxic chemotherapy being used to treat breast cancer; AND
                                                                                                                The treatment must be in combination with a 5‑hydroxytryptamine receptor (5HT3) antagonist and dexamethasone; AND
                                                                                                                Patient must be scheduled to be co‑administered cyclophosphamide and an anthracycline.
                                                                                                                No more than 1 capsule of aprepitant 165 mg will be authorised per cycle of cytotoxic chemotherapy.
C4223                              Aprepitant                                                                   Nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures ‑ Streamlined Authority Code 4223
                                                                                                                The condition must be associated with cytotoxic chemotherapy being used to treat malignancy; AND
                                                                                                                The treatment must be in combination with a 5‑hydroxytryptamine receptor (5HT3) antagonist and dexamethasone; AND
                                                                                                                Patient must be scheduled to be administered a chemotherapy regimen that includes any 1 of the following agents: altretamine; carmustine; cisplatin when a single dose constitutes a cycle of chemotherapy; cyclophosphamide at a dose of 1500 mg per square metre per day or greater; dacarbazine; procarbazine when a single dose constitutes a cycle of chemotherapy; streptozocin.
                                                                                                                No more than 1 capsule of aprepitant 165 mg will be authorised per cycle of cytotoxic chemotherapy.
C4649               P4649          Eribulin                                                                     Locally advanced or metastatic breast cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures ‑ Streamlined Authority Code 4649
                                                                                                                Patient must have progressive disease; AND
                                                                                                                Patient must have failed at least two prior chemotherapeutic regimens for this condition; AND
                                                                                                                The treatment must be the sole PBS‑subsidised therapy for this condition.
C4657               P4657          Paclitaxel, nanoparticle albumin‑bound                                       Stage IV (metastatic) adenocarcinoma of the pancreas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures ‑ Streamlined Authority Code 4657
                                                                                                                The treatment must be in combination with gemcitabine; AND
                                                                                                                The condition must not have been treated previously with PBS‑subsidised therapy; AND
                                                                                                                Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less.
                                                                                                                A patient who has progressive disease when treated with this drug is no longer eligible for PBS‑subsidised treatment with this drug.
C4785               P4785          Cetuximab                                                                    Stage III, IVa or IVb squamous cell cancer of the larynx, oropharynx or hypopharynx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures ‑ Streamlined Authority Code 4785
                                                                                                                Initial